Related Experiment Videos

Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study

G L Bray1, L Muenz, N Makris

  • 1Department of Pediatrics, George Washington University School of Medicine, Washington, DC.

The American Journal of Pediatric Hematology/Oncology
|February 1, 1994
PubMed

Insights

Identifying early childhood indicators for sickle cell disease severity is crucial for timely bone marrow transplants. This study aims to find predictive factors for better patient selection and outcomes.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Genetics

Background:

  • Sickle cell disease (SCD) is curable with bone marrow transplantation (BMT), but suitable candidate identification is challenging.
  • The disease has a variable clinical course, necessitating intervention before chronic organ damage occurs.
  • A clinical severity index is needed to identify high-risk SCD patients for BMT.

Purpose of the Study:

  • To identify early childhood features (< 2 years) predictive of later morbidity or mortality in SCD.
  • To establish objective criteria for selecting pediatric candidates for bone marrow transplantation.
  • To develop a clinical severity index for improved SCD patient management.

Main Methods:

  • Utilized the Cooperative Study of Sickle Cell Disease database with 1,944 pediatric patients (< 12 years).
  • Performed univariate analysis to identify features associated with cerebrovascular accidents and mortality.
  • Defined a new endpoint: the distribution of acute events (pain, acute chest syndrome) and age-specific expected event rates.

Main Results:

  • Low hematocrit was a significant predictor of death in the pediatric cohort.
  • Factors like hematocrit, rate of change of pocked red cell count, and PF40 were associated with cerebrovascular accidents.
  • The study established a method to assess acute event rates for further analysis.

Conclusions:

  • The relationship between SCD aspects and high positive deviance from expected event rates will be assessed.
  • A cohort of 519 infants (< 7 months) followed beyond age two will be used for this assessment.
  • This research aims to refine criteria for BMT in pediatric SCD patients.
Abstract

Related Concept Videos